Renee Gardner
Pediatric Hematology-Oncology · New Orleans, LANPI 1629089149
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,439 of the $24,680 with a category attached, or 70.7%. Global Blood Therapeutics, Inc. accounts for 74.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $10,184 and has fallen 99.2% since, to $85 in 2024.
Across 113 payments — averaging $218.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$18K
- Pfizer$5K
- Novartis$232
- CSL Behring$185
- Novo Nordisk$152
- Servier Pharmaceuticals LLC$144
- plus $1K from 21 others
Across 2 payments — averaging $10,902 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Global Blood Therapeutics, Inc.$15K
- Apo-pharma Inc.$7K
What the payments were for
- Consulting fees$3,79715%
- Speaking & faculty fees$17,43971%
- Travel & lodging$1,0954%
- Food & beverage$2,2519%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 25 | $18,354 |
| Pfizer | 8 | $4,545 |
| Novartis | 15 | $232 |
| CSL Behring | 8 | $185 |
| Novo Nordisk | 8 | $152 |
| Servier Pharmaceuticals LLC | 9 | $144 |
| Seagen Inc. | 3 | $140 |
| Sobi, Inc | 6 | $139 |
| Bioverativ Therapeutics Inc. | 1 | $110 |
| EMD Serono, Inc. | 1 | $100 |
| AstraZeneca(2 entities) | 5 | $93 |
| Emmaus Medical, Inc. | 4 | $73 |
| Bayer | 3 | $66 |
| Octapharma USA, Inc. | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| Y-mabs Therapeutics, Inc. | 1 | $31 |
| BTG International Inc. | 2 | $29 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Axogen | 1 | $24 |
| Epizyme, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| RARE Disease Therapeutics, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Medexus Pharma, Inc. | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Silvergate Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,680 in reported general payments places this provider in the 80th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
- Cori MorrisonNew Orleans$1K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.